A Profile of Patients on ASA or NSAIDs Hospitalized with Gastrointestinal Perforations
BACKGROUND: In a recent clinical trial gastrointestinal tract perforations in patients on nonsteroidal anti-inflammatory drugs (NSAIDs) were found to occur with a frequency of 0.15%, and possibly to be reduced in patients concomitantly using the cytoprotective agent misoprostol.
Saved in:
Main Authors: | James D Bailey, Robert J Bailey, Richard N Fedorak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1995-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1995/239138 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ASA, NSAIDs, Coxibs and Colorectal Cancer Prevention — How Far Have We Come?
by: Martin Fishman
Published: (2004-01-01) -
Massive Gastrointestinal Bleeding Related to NSAID Use in a Patient with Ileorectal Anastomosis
by: Esere Nesiama, et al.
Published: (2024-01-01) -
Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
by: Ragia Hegazy, et al.
Published: (2011-01-01) -
Safety Profile of the New 5-ASA Based Compounds
by: Vinod K Sharma
Published: (1990-01-01) -
NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study
by: Ilja Tachecí, et al.
Published: (2013-01-01)